Atsushi Usami Ph.D Overview
- Firm
- The University...
- Primary Position
-
Partner & Board...
- Primary Industry
-
Healthcare
- Active Board Seats
-
7
- Med. Deal Size
-
- Med. Valuation
-
Atsushi Usami Ph.D General Information
Biography
Dr. Atsushi Usami serves as Partner & Board Director at The University of Tokyo Edge Capital. He served as Board Member at Epigeneron. He serves as Board Member at Goryo Chemical, Edit Force, RegCell and bitBiome. He serves as Board Member at Repertoire Genesis. He focuses on seed/early-stage life science investments: biotech, regenerative medicine, and medical devices. He worked as a strategy consultant at Mitsubishi Research Institute (MRI), serving the pharmaceutical, medical device, and other manufacturing companies across a range of areas including mid-to-long-term management planning and new business development. He also engaged in providing consulting services to government agencies in the fields of international standardization strategy and industry-academia collaboration. He served as a Board Member at Metcela, OriCiro Genomics, and Repertoire Genesis.
Contact Information
Address
- 3rd Floor, South Research Building (Entrepreneur Lab)
- University of Tokyo, 7-3-1 Hongo, Bunkyo-ku
- Tokyo, 113-8485
- Japan
Atsushi Usami Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| The University of Tokyo Edge Capital | Investor | Partner & Board Director | Tokyo, Japan | Venture Capital |
Atsushi Usami Ph.D Board Seats (7)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| bitBiome | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Tokyo, Japan | |
| Bugworks Research | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Saratoga, CA | |
| EditForce | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Fukuoka, Japan | |
| Goryo Chemical | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Sapporo, Japan | |
| Metcela | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Kawasaki, Japan |
Atsushi Usami Ph.D Lead Partner on Deals (17)
Atsushi Usami Ph.D has been the lead partner on 17 deals. Their latest deal was with RegCell, a biotechnology company. The deal was made for on 18-Mar-2025.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| RegCell | 18-Mar-2025 | Later Stage VC | Completed | Biotechnology | ||
| Celaid Therapeutics | 08-May-2024 | Completed | Biotechnology | Tokyo, Japan | ||
| bitBiome | 31-Jul-2023 | Completed | Drug Discovery | Tokyo, Japan | ||
| Violet Therapeutics | 31-May-2023 | Completed | Drug Discovery | Cambridge, MA | ||
| EditForce | 22-May-2023 | Completed | Biotechnology | Fukuoka, Japan | ||
| Bugworks Research | 08-Nov-2021 | Completed | Drug Discovery | Saratoga, CA | ||
| EditForce | 27-Jul-2021 | Completed | Biotechnology | Fukuoka, Japan | ||
| OriCiro Genomics | 20-Jul-2021 | Completed | Biotechnology | Bunkyo, Japan | ||
| Metcela | 24-Feb-2021 | Later Stage VC (Series B) | Completed | Biotechnology | Kawasaki, Japan | |
| bitBiome | 24-Aug-2020 | Early Stage VC (Series B) | Completed | Drug Discovery | Tokyo, Japan |
Atsushi Usami Ph.D Network (125)
Board Members (52)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Pranav Pai | Bugworks Research | 3one4 Capital | Saratoga, CA | |
| Hisako Otoshi | EditForce | EditForce | Fukuoka, Japan | |
| Bugworks Research | Bugworks Research | Saratoga, CA | ||
| EditForce | EditForce | Fukuoka, Japan | ||
| Goryo Chemical | Goryo Chemical | Sapporo, Japan |
Portfolio Executives (61)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Noriko Sakaguchi MD | RegCell | Co-Founder, Executive Vice President, Board Member & Auditor | 18-Mar-2025 | |
| James Ahlers | RegCell | Chief Financial Officer | 18-Mar-2025 | |
| RegCell | Chief Technical Operations Officer | 18-Mar-2025 | ||
| RegCell | Co-Founder & Board Member | 18-Mar-2025 | ||
| RegCell | Outside Auditor & Board Member | 18-Mar-2025 |
Fund Team Members (12)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Hiroyuki Sakamoto | The University of Tokyo Edge Capital | UTEC 4 | Tokyo, Japan |
| Tomotaka Goji Ph.D | The University of Tokyo Edge Capital | UTEC 4 | Tokyo, Japan |
| The University of Tokyo Edge Capital | Tokyo, Japan | ||
| The University of Tokyo Edge Capital | Tokyo, Japan | ||
| The University of Tokyo Edge Capital | Tokyo, Japan |
Atsushi Usami Ph.D Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| UTEC 4 | The University of Tokyo Edge Capital | Venture - General | Closed | 2018 | ||||
| UTEC 3 Limited Partnership | The University of Tokyo Edge Capital | Venture - General | Closed | 2013 | ||||
| UTEC-Innovation Network Corporation of Japan Venture Fund | The University of Tokyo Edge Capital | Venture - General | Closed | 2014 |
Atsushi Usami Ph.D FAQs
-
Who is Atsushi Usami Ph.D?
Dr. Atsushi Usami serves as Partner & Board Director at The University of Tokyo Edge Capital.
-
How much does Atsushi Usami Ph.D typically invest?
Atsushi Usami Ph.D's median deal size is .
-
What is Atsushi Usami Ph.D’s main position?
Atsushi Usami Ph.D’s primary position is Partner & Board Director.
-
What are the contact details for Atsushi Usami Ph.D?
Atsushi Usami Ph.D’s email address is us and his phone number is +81 .
-
How many active board seats does Atsushi Usami Ph.D hold?
Atsushi Usami Ph.D holds 7 board seats including bitBiome, Bugworks Research, EditForce, Goryo Chemical, and Metcela.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
